Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Allianz SE Unsponsored ADR (ALVE) AI Stock Analysis

16 Followers
DE:ALVE

Allianz SE Unsponsored ADR

(Frankfurt:ALVE)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Cash generationSustained large operating and free cash flows over recent years provide durable internal funding for claims, dividends, buybacks and M&A. Reliable absolute cash generation supports balance-sheet flexibility and makes the business less dependent on volatile capital markets for strategic investments.
Negative Factors
Earnings volatilityMaterial historical volatility and documented data inconsistencies reduce confidence in trend reliability and forecasting. For an insurer, unpredictable earnings complicate capital planning, reserving and shareholder returns, raising the risk that stress periods could force capital actions or underwriting pullbacks.

Allianz SE Unsponsored ADR (ALVE) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%DE:ALVE+33.08%EWG+9.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 196.05B
Dividend Yield
3.69%
Average Volume (3M)
244
Price to Earnings (P/E)
15.0
Beta (1Y)
0.71
Revenue Growth
20.64%
EPS Growth
16.94%
Country
Germany
Employees
155,785
Sector
Financial
Sector Strength
68
Industry
Insurance - Diversified

Allianz SE Unsponsored ADR Business Overview & Revenue Model

Company Description

Allianz SE, through its various subsidiaries, operates as a global financial services conglomerate, specializing in property-casualty insurance, life and health insurance, and comprehensive asset management services. Its Property-Casualty division of...

Allianz SE Unsponsored ADR Earnings Call Summary

Earnings Call Date:Aug 06, 2026(Q2-2026)|% Change Since:5.09%|Next Earnings Date:Nov 11, 2026
Earnings Call SentimentPositive

The call presents strong, broad-based operational performance across P&C, Life & Health and Asset Management with robust metrics (operating profit +9%, record EUR 84bn net inflows, solvency 225%) and clear strategic progress (targeted M&A, AI rollout, ongoing productivity gains). Headwinds are acknowledged — elevated Nat Cat risk (Q3 wildfires), AGCS reserve strengthening, market/disposal noise affecting reported net income, and cycle softness/reinsurance dynamics — but management emphasizes conservative balance sheet positioning and active cycle management. Overall, the positives (solid growth, record inflows, high solvency and disciplined strategy execution) outweigh the manageable near-term risks identified.

Positive Updates

Strong Overall Financial Performance
Total business volume of EUR 99 billion (H1), up 4.3% year-on-year; operating profit of EUR 9.4 billion, up 9% YoY. Management reports excellent first-half results with momentum building into Q2.

Negative Updates

Near-term Natural Catastrophe Risk and Wildfires
Management expects increased Nat Cat activity in Q3 (wildfires in France, Spain, etc.); highlighted protection and affordability gaps for wildfire risk and potential uninsurable pockets in high-risk locations.

Company Guidance

Allianz kept its full‑year operating profit guidance at EUR 17.4 billion ± EUR 1.0 billion, saying H1 performance leaves it confident to hit its 2026 targets while noting H2 volatility (FX, Nat Cat, markets) could affect outcomes. H1 operating profit was EUR 9.4 billion (+9% y/y), shareholder core net income was up 9% and core EPS up 10%, total business volume was EUR 99 billion (+4.3%), and solvency stood at 225% (highest since 2018). Key segment metrics underpinning the guidance include P&C: ~EUR 50 billion volume, 6% internal growth, combined ratio 91.4%, expense ratio improvement ~30 bps and P&C operating profit EUR 4.9 billion (+9%); MidCorp combined ratio 88%; health & protection operating profit EUR 1.2 billion; Life & Health: VONB EUR 2.4 billion (VONB +4% adj), PVNBP +9% in Q2 and L&H operating profit +5% F/X‑adj; Asset Management: third‑party net inflows EUR 84 billion, annualized organic AUM growth ~8% (PIMCO 9%, AGI 7%), revenues +16% F/X‑adj and operating profit +19% F/X‑adj. Operating capital generation was 11% in H1 (vs. a 2027 target of 24–25 pp), and management noted they’ve strengthened P&C reserves for claims‑inflation uncertainty.

Allianz SE Unsponsored ADR Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

DE:ALVE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
BRK.BBRK.B86Outperform$1.19T14.5711.86%―3.93%36.30%
ACGLACGL83Outperform$36.78B8.9418.35%―-5.29%14.08%
HIGHIG82Outperform$36.08B8.2824.13%1.74%4.08%34.70%
AIGAIG77Outperform$42.11B13.221.83%2.33%-21.96%9.77%
AEGAEG74Outperform$12.54B11.7312.23%5.66%24.97%―
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%

* Financial Sector Average

Performance Comparison

-10%0%10%20%30%DE:ALVEAEGAIGACGLHIGBRK.BDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:ALVE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:ALVEAllianz SE Unsponsored ADR45.4011.2933.08%
AEGAegon Nv8.581.3218.17%
AIGAmerican International Group, Inc.81.717.269.76%
ACGLArch Capital110.6822.9226.12%
HIGHartford Insurance Group Inc138.1112.429.88%
BRK.BBerkshire Hathaway B579.0985.9417.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.